Dr. George John Harocopos, MD

Dr. Harocopos practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Harocopos' NPI, 1427074657, was assigned on July 14, 2006. Dr. Harocopos graduated from Virginia Commonwealth University, School of Medicine in 2000. Dr. Harocopos holds Missouri license 2004009695.

Dr. Harocopos' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Harocopos also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Harocopos' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Harocopos is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Harocopos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harocopos practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Harocopos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Harocopos is licensed in Missouri.

CMS data shows 452 Medicare services from Dr. Harocopos across 8 procedure codes in 2024, for 143 Medicare patients. Medicare paid $9,311 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Harocopos in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harocopos' median patient age at 73, with 58% women.

In 2024, Dr. Harocopos wrote 11 Medicare Part D claims. They cover 10 drugs, with $33,179 in total drug cost. In 2020, CMS named 933 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Harocopos for performance year 2024, reported as part of a group. Dr. Harocopos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Harocopos, published from 2011 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Keratoplasty, Penetrating, Corneal Diseases and Tomography, Optical Coherence. Dr. Harocopos has published most often in Am J Ophthalmol Case Rep. Dr. Harocopos' most frequent co-authors are Steven Michael Couch, MD, Asim V. Farooq and Arsham Sheybani, MD.

CMS Open Payments shows 1 general payment to Dr. Harocopos from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $107.

Dr. Harocopos graduated from Virginia Commonwealth University, School of Medicine in 2000.